BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 9080123)

  • 1. Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model.
    Ju DW; Cao X; Acres B
    Cancer Gene Ther; 1997; 4(2):139-44. PubMed ID: 9080123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic effect of vaccinia virus secreting granulocyte-macrophage colony-stimulating factor on pulmonary metastatic melanoma].
    Ju D; Cao X; Ma S
    Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):165-8. PubMed ID: 9387245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.
    Cao X; Huang X; Ju DW; Zhang W; Hamada H; Wang J
    Cancer Gene Ther; 2000 Feb; 7(2):177-86. PubMed ID: 10770625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of intratumoral injections of vaccinia virus MVA expressing GM-CSF and immunization with DNA vaccine prolongs the survival of mice bearing HPV16 induced tumors with downregulated expression of MHC class I molecules.
    Nemeckova S; Smahel M; Hainz P; Mackova J; Zurkova K; Gabriel P; Indrova M; Kutinova L
    Neoplasma; 2007; 54(4):326-33. PubMed ID: 17822323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intraperitoneally administered recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) on the cytotoxic potential of murine peritoneal cells.
    Klimp AH; Regts J; Scherphof GL; de Vries EG; Daemen T
    Br J Cancer; 1999 Jan; 79(1):89-94. PubMed ID: 10408698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity.
    Wang L; Qi X; Sun Y; Liang L; Ju D
    Cancer Gene Ther; 2002 Oct; 9(10):819-24. PubMed ID: 12224022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active specific immunotherapy of pulmonary metastasis with vaccinia melanoma oncolysate prepared from granulocyte/macrophage-colony-stimulating-factor-gene-encoded vaccinia virus.
    Ju DW; Cao X; Acres B
    J Cancer Res Clin Oncol; 1996; 122(12):716-22. PubMed ID: 8954168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2.
    Vallera DA; Taylor PA; Aukerman SL; Blazar BR
    Cancer Res; 1993 Sep; 53(18):4273-80. PubMed ID: 8364923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant vaccinia virus expressing cytokine GM-CSF as tumor vaccine.
    Chatterjee SK; Qin H; Manna S; Tripathi PK
    Anticancer Res; 1999; 19(4B):2869-73. PubMed ID: 10652566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of recombinant vaccinia virus expressing GM-CSF and its use as tumor vaccine.
    Qin HX; Chatterjee SK
    Gene Ther; 1996 Jan; 3(1):59-66. PubMed ID: 8929912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor.
    Toda M; Martuza RL; Rabkin SD
    Mol Ther; 2000 Oct; 2(4):324-9. PubMed ID: 11020347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of irradiated tumor vaccine and infusion of granulocyte-macrophage colony-stimulating factor and interleukin-12 on established gliomas in rats.
    Chen JC; Chen Y; Wu JM; Su YH; Tai KF; Tseng SH
    Cancer Immunol Immunother; 2006 Jul; 55(7):873-83. PubMed ID: 16133106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
    Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice.
    Cao X; Ju DW; Tao Q; Wang J; Wan T; Wang BM; Zhang W; Hamada H
    Gene Ther; 1998 Aug; 5(8):1130-6. PubMed ID: 10326037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF.
    Shi FS; Weber S; Gan J; Rakhmilevich AL; Mahvi DM
    Cancer Gene Ther; 1999; 6(1):81-8. PubMed ID: 10078967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
    J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma.
    Mastrangelo MJ; Maguire HC; Eisenlohr LC; Laughlin CE; Monken CE; McCue PA; Kovatich AJ; Lattime EC
    Cancer Gene Ther; 1999; 6(5):409-22. PubMed ID: 10505851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery.
    Pan PY; Li Y; Li Q; Gu P; Martinet O; Thung S; Chen SH
    Cancer Immunol Immunother; 2004 Jan; 53(1):17-25. PubMed ID: 12955480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.